HomeGL9 • FRA
add
Glanbia plc
Previous close
€14.57
Day range
€14.73 - €14.73
Year range
€14.00 - €19.43
Market cap
3.89B EUR
Avg Volume
1.00
P/E ratio
13.89
Dividend yield
2.50%
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 907.80M | -34.49% |
Operating expense | 208.50M | 13.87% |
Net income | 71.65M | -25.98% |
Net profit margin | 7.89 | 12.88% |
Earnings per share | — | — |
EBITDA | 125.80M | 13.13% |
Effective tax rate | 15.56% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 300.90M | 19.07% |
Total assets | 4.05B | 9.70% |
Total liabilities | 1.89B | 17.06% |
Total equity | 2.15B | — |
Shares outstanding | 261.92M | — |
Price to book | 1.77 | — |
Return on assets | 5.80% | — |
Return on capital | 7.32% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 71.65M | -25.98% |
Cash from operations | 43.60M | 536.50% |
Cash from investing | -170.75M | -288.36% |
Cash from financing | 38.25M | 129.93% |
Net change in cash | -89.75M | -178.73% |
Free cash flow | 73.94M | 6.26% |
About
Glanbia plc is an Irish multinational nutrition company that owns several consumer brands that produce lifestyle products such as food supplements. Glanbia is headquartered in Kilkenny, Ireland with over 5,534 employees in over 30 countries around the world. Glanbia’s consumer brands and ingredients are sold or distributed in over 130 countries. North America is the company’s largest market, and it also has a presence in Europe, Middle East, Asia Pacific and Latin America. Glanbia's primary listing is on
Euronext Dublin. Glanbia comprises three divisions: Glanbia Nutritionals, Glanbia Performance Nutrition and Joint Ventures.
Given the company's origins in the co-operative movement, farmer-suppliers of the company retain a significant interest in the company. Tirlán remains the largest shareholder in Glanbia plc. as of 2022 and retains the right to nominate a number of non-executive directors to the board of the company in line with their mutual Relationship Agreement. Wikipedia
Founded
1997
Website
Employees
5,534